Related Experiment Video
Updated: Aug 14, 2026
08:57
Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
Published on: May 17, 2024
Neonatal mastocytosis with pachydermic bullous skin without c-Kit 816 mutation
T Walker1, G von Komorowski, W Scheurlen
1Department of Dermatology, Mannheim University Clinic, Mannheim, Germany.
Dermatology (Basel, Switzerland)
|December 2, 2005
Summary
This case report details a rare instance of diffuse cutaneous bullous mastocytosis in an infant. Further research is needed to understand the prognosis of c-Kit-negative variants.
Area of Science:
- Dermatology
- Pediatrics
- Hematology
Background:
- Bullous mastocytosis is a rare mast cell disease variant characterized by extensive blistering.
- Mast cell proteases cause dermoepidermal separation, leading to bullae formation.
Observation:
- A 3-week-old girl presented with diffuse cutaneous bullous mastocytosis, pachydermia, and extensive skin folding.
- Diagnosis was confirmed via immunohistochemistry, enzyme reactions, and elevated serum/urine markers (tryptase, histamine, 1.4-methylimidazol acetic acid).
- Bone marrow analysis revealed 1% mast cells, with no c-Kit mutation found; systemic involvement was excluded.
Findings:
- The patient had c-Kit-negative diffuse bullous mastocytosis.
- Key diagnostic markers included elevated tryptase and histamine levels.
Implications:
- The prognosis for c-Kit-negative diffuse bullous mastocytosis remains unknown.
- Regular blood monitoring and screening for ovarian cancer and bone marrow abnormalities are recommended for patients.
- This case highlights the importance of comprehensive diagnostic approaches in rare pediatric dermatological conditions.
